180 Wealth Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.76M | Buy |
44,833
+279
| +0.6% | +$32.7K | 0.58% | 40 |
|
|
2026
Q1 | $5.36M | Sell |
44,554
-158
| -0.4% | -$18.2K | 0.61% | 38 |
|
|
2025
Q4 | $4.71M | Buy |
44,712
+3,726
| +9% | +$350K | 0.54% | 39 |
|
|
2025
Q3 | $3.44M | Buy |
40,986
+1,387
| +4% | +$114K | 0.42% | 55 |
|
|
2025
Q2 | $3.13M | Buy |
39,599
+4,970
| +14% | +$395K | 0.44% | 56 |
|
|
2025
Q1 | $3.11M | Buy |
34,629
+3,106
| +10% | +$290K | 0.5% | 47 |
|
|
2024
Q4 | $3.14M | Buy |
31,523
+2,177
| +7% | +$224K | 0.49% | 48 |
|
|
2024
Q3 | $3.33M | Buy |
29,346
+786
| +3% | +$93.4K | 0.52% | 44 |
|
|
2024
Q2 | $3.68M | Buy |
28,560
+87
| +0.3% | +$11.2K | 0.6% | 37 |
|
|
2024
Q1 | $3.76M | Buy |
28,473
+972
| +4% | +$120K | 0.68% | 34 |
|
|
2023
Q4 | $3.11M | Sell |
27,501
-650
| -2% | -$67.5K | 0.62% | 36 |
|
|
2023
Q3 | $2.9M | Buy |
28,151
+1,345
| +5% | +$145K | 0.65% | 32 |
|
|
2023
Q2 | $3.06M | Sell |
26,806
-4,224
| -14% | -$480K | 0.67% | 28 |
|
|
2023
Q1 | $3.3M | Sell |
31,030
-1,482
| -5% | -$160K | 0.77% | 27 |
|
|
2022
Q4 | $3.47M | Sell |
32,512
-1,578
| -5% | -$161K | 0.82% | 25 |
|
|
2022
Q3 | $2.94M | Buy |
34,090
+176
| +0.5% | +$15.7K | 0.81% | 25 |
|
|
2022
Q2 | $3.13M | Buy |
33,914
+2,441
| +8% | +$216K | 0.8% | 27 |
|
|
2022
Q1 | $2.7M | Buy |
31,473
+2,966
| +10% | +$234K | 0.59% | 43 |
|
|
2021
Q4 | $2.28M | Buy |
28,507
+1,176
| +4% | +$93.7K | 0.51% | 49 |
|
|
2021
Q3 | $2.14M | Buy |
27,331
+1,664
| +6% | +$127K | 0.47% | 58 |
|
|
2021
Q2 | $1.93M | Sell |
25,667
-237
| -0.9% | -$17.6K | 0.44% | 61 |
|
|
2021
Q1 | $1.96M | Buy |
25,904
+900
| +4% | +$66.4K | 0.49% | 59 |
|
|
2020
Q4 | $1.99M | Buy |
25,004
+374
| +2% | +$28.6K | 0.57% | 45 |
|
|
2020
Q3 | $1.84M | Buy |
24,630
+1,905
| +8% | +$149K | 0.69% | 30 |
|
|
2020
Q2 | $1.73M | Buy |
22,725
+7,635
| +51% | +$575K | 0.69% | 31 |
|
|
2020
Q1 | $1.11M | Sell |
15,090
-475
| -3% | -$37.3K | 0.57% | 46 |
|
|
2019
Q4 | $1.36M | Sell |
15,565
-924
| -6% | -$75.9K | 0.54% | 46 |
|
|
2019
Q3 | $1.33M | Sell |
16,489
-120
| -0.7% | -$9.62K | 0.59% | 42 |
|
|
2019
Q2 | $1.33M | Buy |
16,609
+1,714
| +12% | +$131K | 0.6% | 41 |
|
|
2019
Q1 | $1.11M | Sell |
14,895
-1,024
| -6% | -$76.6K | 0.5% | 52 |
|
|
2018
Q4 | $1.08M | Sell |
15,919
-486
| -3% | -$34.3K | 0.5% | 54 |
|
|
2018
Q3 | $1.11M | Buy |
16,405
+3,809
| +30% | +$243K | 0.51% | 50 |
|
|
2018
Q2 | $730K | Buy |
12,596
+7,615
| +153% | +$430K | 0.36% | 88 |
|
|
2018
Q1 | $258K | Buy |
4,981
+275
| +6% | +$14.9K | 0.13% | 189 |
|
|
2017
Q4 | $253K | Buy |
+4,706
| New | +$261K | 0.13% | 191 |
|
Other funds holding MRK
ECSS
ATO
180 Wealth Advisors's MRK Position: Q2 2026 in Review
180 Wealth Advisors increased its Merck (MRK) stake by 0.63% in Q2 2026, buying an estimated $32.7K and bringing the position to 44,833 shares worth $5.76M. The position accounts for 0.58% of the portfolio, ranked #40.
180 Wealth Advisors first reported a position in MRK in Q4 2017 and has held it in 35 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- 180 Wealth Advisors held 44,833 shares of Merck worth $5.76M as of Q2 2026.
- 180 Wealth Advisors bought 279 Merck shares in Q2 2026, an estimated $32.7K.
- Merck made up 0.58% of 180 Wealth Advisors's portfolio in Q2 2026, its #40 holding.
- 180 Wealth Advisors first reported a position in Merck in Q4 2017 and has held it in 35 quarters since.
- 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.